![Sven Klussmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sven Klussmann
Chief Tech/Sci/R&D Officer at NOXXON Pharma AG
Network origin in Sven Klussmann first degree
Entity | Entity type | Industry | |
---|---|---|---|
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.
15
| Subsidiary | Biotechnology | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sven Klussmann via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
TME PHARMA N.V. | Biotechnology | Director/Board Member Chairman Director/Board Member Founder Chief Executive Officer Director/Board Member Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Bayer Corp.
![]() Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Chairman Director/Board Member | |
NOXXON Pharma NV Niederlassung Deutschland
![]() NOXXON Pharma NV Niederlassung Deutschland BiotechnologyHealth Technology NOXXON Pharma NV Niederlassung Deutschland operates as a German biotechnology company. The private company is based in Berlin, Germany. | Biotechnology | Director/Board Member Director of Finance/CFO | |
ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Allecra Therapeutics GmbH
![]() Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Roche Innovation Center Copenhagen A/S
![]() Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Autonomic Technologies, Inc.
![]() Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Equipment/Instruments | Director/Board Member | |
Institut Für Medizinische Mikrobiologie | College/University | Doctorate Degree | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Medlumics SL
![]() Medlumics SL Medical SpecialtiesHealth Technology Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain. | Medical Specialties | Director/Board Member | |
HighLife SAS
![]() HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member | |
T-Knife GmbH
![]() T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
Arvelle Therapeutics International GmbH
![]() Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Director-Back Office Operation | |
JenaValve Technology, Inc.
![]() JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member | |
MINERALYS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Ariceum Therapeutics GmbH
![]() Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Philipps University of Marburg | College/University | Doctorate Degree | |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Chief Executive Officer | |
VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
Andera Partners SCA
![]() Andera Partners SCA Investment ManagersFinance Andera Partners SCA (Andera Partners) is a private equity firm founded in 2001 by Pierre-Michel Passy. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Vivaldi Biosciences AG
![]() Vivaldi Biosciences AG BiotechnologyHealth Technology Vivaldi Biosciences AG is a venture-backed company that focuses on research and development. It develops genetically engineered intranasal vaccines for epidemic and pandemic viral respiratory diseases. The company is headquartered in Vienna, Austria. | Biotechnology | Director/Board Member | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing | |
RESVERLOGIX CORP. | Pharmaceuticals: Major | Chairman | |
Vivaldi Biosciences, Inc.
![]() Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Drugstore Chains | Director/Board Member | |
Exosome Diagnostics, Inc.
![]() Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member | |
Horizon Therapeutics Switzerland GmbH
![]() Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
ZENITH CAPITAL CORP. | Biotechnology | Director/Board Member | |
Lumendi Ltd.
![]() Lumendi Ltd. Medical SpecialtiesHealth Technology Lumendi Ltd. develops medical devices for the treatment of gastrointestinal conditions. The private company is based in Maidenhead, UK. The British company was founded in 2014 by Peter Johann. Peter Johann has been the CEO since 2014. | Medical Specialties | Chief Executive Officer | |
INSEAD | College/University | Masters Business Admin | |
Sapiens Steering Brain Stimulation BV
![]() Sapiens Steering Brain Stimulation BV Electronic Equipment/InstrumentsElectronic Technology Sapiens Steering Brain Stimulation BV develops medical devices. The company was founded by Sjaak Deckers in 2011 and is headquartered in Eindhoven, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
University of California San Diego | College/University | Doctorate Degree | |
Caerus Consulting AS
![]() Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway. | Pharmaceuticals: Major | Director/Board Member | |
University of Wisconsin | College/University | Undergraduate Degree | |
EUROBIO SCIENTIFIC | Medical Specialties | Corporate Officer/Principal | |
JenaValve Technology GmbH
![]() JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Takeda Pharmaceuticals International, Inc.
![]() Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Beactica Therapeutics AB
![]() Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Medical Distributors | Director/Board Member |
Statistics
International
Germany | 13 |
France | 11 |
United States | 11 |
Switzerland | 7 |
Sweden | 3 |
Sectoral
Health Technology | 36 |
Consumer Services | 6 |
Commercial Services | 4 |
Electronic Technology | 3 |
Distribution Services | 3 |
Operational
Director/Board Member | 116 |
Corporate Officer/Principal | 32 |
Chairman | 23 |
Chief Executive Officer | 20 |
Independent Dir/Board Member | 18 |
Most connected contacts
Insiders | |
---|---|
Joseph deBethizy | 29 |
Denis Lucquin | 26 |
Olivier Litzka | 21 |
Frank Morich | 21 |
Peter Johann | 18 |
Jarl Ulf Birger Jungnelius | 16 |
Walter Wenninger | 14 |
Iain Peter Murray Buchanan | 13 |
Bertram Köhler | 13 |
Aram Andrew Mangasarian | 11 |
Donald Munoz | 11 |
Matthias Baumann | 7 |
Oliver Höppner | 5 |
Thomas Klein | 2 |
Jens-Peter Fürste | 2 |
- Stock Market
- Insiders
- Sven Klussmann
- Company connections